logo

Abbvie (ABBV)



Trade ABBV now with
  Date
  Headline
8/5/2019 8:32:20 AM AbbVie Submits NDA For Elagolix For Management Of Heavy Menstrual Bleeding Associated With Uterine Fibroids In Women
7/26/2019 7:46:50 AM AbbVie Reports Q2 EPS Of $0.49 On A GAAP Basis; Adj. EPS Of $2.26
7/15/2019 8:09:26 AM AbbVie Acquires Privately Held Seattle-based Mavupharma; Financial Terms Not Disclosed
7/9/2019 8:10:28 AM CytomX Says Target Selection Triggers $10 Mln Payment From AbbVie
6/25/2019 9:13:50 AM AbbVie Gets Positive Recommendation From INESSS For Combination VENCLEXTA With Rituximab As CLL Treatment
6/25/2019 6:45:00 AM AbbVie To Acquire Allergan In Cash And Stock Transaction For Transaction Equity Value Of About $63 Bln
6/24/2019 8:48:35 AM AbbVie Says FDA Lifted Partial Clinical Hold Placed On CANOVA Or M13-494
6/20/2019 1:59:50 PM AbbVie Declares Quarterly Dividend Of $1.07/share, Payable Aug. 15/ Record July 15
6/6/2019 9:19:22 AM AbbVie Gets Canada' Positive Recommendation For VENCLEXTA -Rituximab As Treatment For Chronic Lymphocytic Leukemia
5/30/2019 8:46:10 AM AbbVie Presents Results From Several Studies And Trials Investigating Medicines Across More Than 15 Cancers
5/30/2019 8:03:41 AM AbbVie Says Its MAVIRET Now Listed In New Brunswick
5/17/2019 8:51:26 AM AbbVie Provides Update On Depatuxizumab Mafodotin, An Investigational Medicine For Newly Diagnosed Glioblastoma